Related Experiment Video
Updated: Jul 23, 2025

12:21
Generating Recombinant Avian Herpesvirus Vectors with CRISPR/Cas9 Gene Editing
Published on: January 7, 2019
13.4K
Generation of an Avian Myeloblastosis Virus (AMV) Reverse Transcriptase Prime Editor
Yi-Ting Tsai1, Bruna Lopes da Costa1,2,3, Salvatore Marco Caruso1,2,3,4
1Department of Biomedical Engineering, Columbia University, New York, NY, USA.
Advances in Experimental Medicine and Biology
|July 13, 2023
Summary
Prime editing offers a new gene editing approach for inherited retinal diseases. This study developed a novel prime editor using avian myeloblastosis virus reverse-transcriptase for precise genetic correction.
Area of Science:
- Molecular Biology
- Gene Editing Technologies
- Ophthalmology
Background:
- Inherited retinal diseases (IRDs) involve over 280 genes, presenting significant challenges for gene editing therapies.
- Traditional genome editing methods often cause complications due to their reliance on double-strand breaks.
- Prime editing (PE) is a promising double-strand break-independent gene editing technology with potential for treating IRDs.
Purpose of the Study:
- To develop a novel prime editor system utilizing avian myeloblastosis virus (AMV)-reverse transcriptase (RT).
- To demonstrate the efficacy of the developed prime editor for precise genetic modifications relevant to IRDs.
Main Methods:
- Construction of a prime editor system by fusing a SpCas9 nickase mutant with an AMV-RT.
- Design and utilization of a prime editing guide RNA (pegRNA) for target site recognition and editing.
- Application of the developed prime editor in HEK293 cells to introduce a specific mutation (PRPH2 c.828+1G>A).
Main Results:
- Successful development of a functional prime editor based on AMV-RT.
- Demonstrated capability of the prime editor to install the PRPH2 c.828+1G>A mutation in HEK293 cells.
- The new system shows potential for precise correction of mutations associated with IRDs.
Conclusions:
- The AMV-RT-based prime editor is a viable alternative for gene editing applications.
- This technology holds promise for developing targeted therapies for a wide range of inherited retinal diseases.
- Further research can explore the application of this system for diverse genetic mutations causing IRDs.
Related Concept Videos
Retrovirus Life Cycles
46.2K
Retroviruses have a single-stranded RNA genome that undergoes a special form of replication. Once the retrovirus has entered the host cell, an enzyme called reverse transcriptase synthesizes double-stranded DNA from the retroviral RNA genome. This DNA copy of the genome is then integrated into the host’s genome inside the nucleus via an enzyme called integrase. Consequently, the retroviral genome is transcribed into RNA whenever the host’s genome is transcribed, allowing the...
46.2K
Viral Recombination
23.5K
Cells are sometimes infected by more than one virus at once. When two viruses disassemble to expose their genomes for replication in the same cell, similar regions of their genomes can pair together and exchange sequences in a process called recombination. Alternatively, viruses with segmented genomes can swap segments in a process called reassortment.
23.5K

